Cytosorbents (CTSO) Misses Q2 EPS by 7c

Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.11), $0.07 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $12 million versus the consensus estimate of $12.27 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• ATN International (ATNI) Misses Q1 EPS by 46c ; Offers Guidance
• Universal Health Realty (UHT) Reports Q1 EPS of $0.38
• Plexus Corp (PLXS) Tops Q2 EPS by 7c